We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.66%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$89.3B
AUM Growth
+$8.23B
(+10%)
Cap. Flow
+$1.9B
Cap. Flow
% of AUM
2.12%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
4,460
New
1,490
Increased
1,679
Reduced
1,235
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$60.1M |
| 2 |
TSMC
TSM
|
+$59.1M |
| 3 |
Tesla
TSLA
|
+$56M |
| 4 |
Apple
AAPL
|
+$55.2M |
| 5 |
Amazon
AMZN
|
+$47.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ex US ETF
ACWX
|
+$102M |
| 2 |
Everest Group
EG
|
+$27.4M |
| 3 |
Chevron
CVX
|
+$25M |
| 4 |
Wells Fargo
WFC
|
+$24.9M |
| 5 |
Crane NXT
CXT
|
+$13.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.27% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 12.17% |
| 4 | Consumer Discretionary | 11.18% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FORG
2126
DELISTED
ForgeRock, Inc.
FORG
| $1.35M | ﹤0.01% |
65,615
+6,272
| +11% | +$126K |
|
|
INFN
2127
DELISTED
Infinera Corporation Common Stock
INFN
| $1.35M | ﹤0.01% |
278,800
+478
| +0.2% | +$2.63K |
|
2128
Toronto Dominion Bank
TD
$200B
| $1.34M | ﹤0.01% |
+21,688
| New | +$1.3M |
|
2129
Century Aluminum
CENX
$5.07B
| $1.34M | ﹤0.01% |
154,095
-1,446
| -0.9% | -$12.6K |
|
2130
Anika Therapeutics
ANIK
$287M
| $1.34M | ﹤0.01% |
51,713
+2,391
| +5% | +$64K |
|
2131
Vanda Pharmaceuticals
VNDA
$302M
| $1.34M | ﹤0.01% |
202,708
+9,100
| +5% | +$58.3K |
|
2132
Lifestance Health
LFST
$4.14B
| $1.33M | ﹤0.01% |
146,164
+30,933
| +27% | +$257K |
|
2133
Warby Parker
WRBY
$3.27B
| $1.33M | ﹤0.01% |
113,753
+3,723
| +3% | +$42.4K |
|
2134
NETGEAR
NTGR
$635M
| $1.33M | ﹤0.01% |
93,628
-556
| -0.6% | -$8.39K |
|
2135
Keros Therapeutics
KROS
$221M
| $1.32M | ﹤0.01% |
32,953
+4,862
| +17% | +$213K |
|
2136
iShares Russell Mid-Cap ETF
IWR
$57.4B
| $1.32M | ﹤0.01% |
18,073
-5,175
| -22% | -$360K |
|
2137
Nicolet Bankshares
NIC
$3.62B
| $1.32M | ﹤0.01% |
19,383
+966
| +5% | +$61.2K |
|
2138
Woori Financial
WF
$17.6B
| $1.31M | ﹤0.01% |
+48,770
| New | +$1.32M |
|
|
PNT
2139
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $1.31M | ﹤0.01% |
145,066
+31,742
| +28% | +$280K |
|
2140
First Advantage
FA
$4.12B
| $1.31M | ﹤0.01% |
85,206
-5,619
| -6% | -$75.4K |
|
2141
Life Time Group Holdings
LTH
$9.79B
| $1.31M | ﹤0.01% |
66,742
-775
| -1% | -$14.8K |
|
2142
CryoPort
CYRX
$762M
| $1.31M | ﹤0.01% |
75,947
+14,498
| +24% | +$297K |
|
2143
Compass
COMP
$9.66B
| $1.31M | ﹤0.01% |
373,740
+15,640
| +4% | +$51.3K |
|
2144
Huazhu Hotels Group
HTHT
$13B
| $1.31M | ﹤0.01% |
+33,726
| New | +$1.47M |
|
2145
Dole
DOLE
$1.32B
| $1.3M | ﹤0.01% |
+96,484
| New | +$1.24M |
|
2146
Titan Machinery
TITN
$445M
| $1.3M | ﹤0.01% |
44,170
+11,384
| +35% | +$343K |
|
|
INBX
2147
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.3M | ﹤0.01% |
50,169
+5,611
| +13% | +$131K |
|
2148
PetMed Express
PETS
$42.3M
| $1.3M | ﹤0.01% |
94,069
-25,399
| -21% | -$381K |
|
|
OPI
2149
DELISTED
Office Properties Income Trust
OPI
| $1.29M | ﹤0.01% |
168,071
-3,319
| -2% | -$25.1K |
|
2150
BlueLinx
BXC
$706M
| $1.29M | ﹤0.01% |
13,799
-440
| -3% | -$35.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2023 Portfolio in Review
As of Q2 2023, RhumbLine Advisers held 4,460 positions worth $89.3B, up 10% from $81B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
RhumbLine Advisers's Q2 2023 filing shows 1,490 new, 1,679 increased, 1,235 reduced and 38 closed positions. Its largest new stake was TSMC: 635,517 shares worth $64.1M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $102M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q2 2023 buy was TSMC: 635,517 shares worth $64.1M.
- RhumbLine Advisers added most to Microsoft in Q2 2023, an estimated $60.1M increase.
- RhumbLine Advisers's biggest Q2 2023 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $102M.
- RhumbLine Advisers fully exited Everest Group in Q2 2023, selling an estimated $27.4M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $89.3B portfolio in Q2 2023.
- RhumbLine Advisers opened 1,490 new positions and closed 38 in Q2 2023.
- RhumbLine Advisers's portfolio value rose 10% quarter-over-quarter to $89.3B.
Based on RhumbLine Advisers's 13F filing for Q2 2023, filed 8 Aug 2023.